Flexartal
Brand names,
Flexartal
Analogs
Flexartal
Brand Names Mixture
Flexartal
Chemical_Formula
C12H24N2O4
Flexartal
RX_link
http://www.rxlist.com/cgi/generic/carisop.htm
Flexartal
fda sheet
Flexartal
msds (material safety sheet)
Flexartal
Synthesis Reference
Berger, Ludwig, U.S. Pat. 2,937,119 (1960)
Flexartal
Molecular Weight
260.33 g/mol
Flexartal
Melting Point
92-93 oC
Flexartal
H2O Solubility
0.3 mg/ml
Flexartal
State
Solid
Flexartal
LogP
1.498
Flexartal
Dosage Forms
Talets
Flexartal
Indication
For the relief of discomfort associated with acute, painful, musculoskeletal conditions.
Flexartal
Pharmacology
Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.
Flexartal
Absorption
No information avaliable
Flexartal
side effects and Toxicity
Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives
Flexartal
Patient Information
Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to
strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine
oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or
operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If
dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your
physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin
rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose
therapy.
Flexartal
Organisms Affected
Humans and other mammals